Quantcast
Channel: BXLT – drkkd.com
Browsing latest articles
Browse All 16 View Live

Biotech Trade Alerts Archive -2016-04-29- $NVO, $FBIO, $ABBV, $AGEN, $BXLT,...

DRKKD.com Real Time Biotech Trade Alert Service April 29, 2016. Tickers covered: NVO, FBIO, ABBV, AGEN, BXLT, CELG, ITCI, KERX, BMY, ALKS, INSY, ACOR, ALXN, UTHR

View Article


Premarket Biotech Digest: $KERX Gains, $GILD Results, $AMGN Beats

View Article


$BXLT CHMP recommends approval of HyQvia in pediatric patients

Baxalta (BXLT) announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending approval of its HyQvia (Human Normal...

View Article

$KMDA receives two milestone payments

Kamada (KMDA) announced the receipt of two milestone payments from Chiesi Farmaceutici S.p.A. and Baxalta (BXLT). The milestone payment from Chiesi was based on the filing of a Marketing Authorization...

View Article

Biotech Trade Alerts Archive -2016-05-02-$PGNX, $MCRB, $CEMP, $PRTX, $KMDA,...

DRKKD.com Real Time Biotech Trade Alert Service May 2, 2016. Tickers covered: PGNX, MCRB, CEMP, PRTX, KMDA, NRX, REGN, MRNS, PCRX, BXLT, BIND

View Article


Premarket Biotech Digest: $TNXP Completes Enrollment in Phase 3 Study,...

View Article

Premarket Biotech Digest: $PTLA Betrixaban Data, $RLYP Gets a Boost, $JAZZ...

View Article

$SHPG completes merger with $BXLT

Shire Plc (SHPG) has completed its merger with Baxalta (BXLT). The combined company now has 22,000 employees in more than 100 countries and is expected to deliver over $20B in revenue by 2020.

View Article


OncoNova Therapeutics $ONTX Before ASCO

OncoNova Therapeutics $ONTX is a small company in a phase 3 trial for a rare disease and has enrolled at least a few patients in its 225-patient global trial. Lead product candidate Rigosertib is...

View Article


Premarket Biotech Digest: $OPK Insider Purchases Continue, $EXEL Upside,...

View Article
Browsing latest articles
Browse All 16 View Live